.png){kind=icon}
.png){kind=icon}
Return
Motor placebo effect in obesity: how ergogenic aids can decrease fatigue and improve motor performance
.png){kind=icon}
OA
AI
DOI：10.1007/s40519-025-01794-5.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Obesity is associated with increased perceived fatigue and reduced physical activity. This study tested whether a placebo ergogenic treatment could reduce perceived exertion and enhance motor performance in individuals with obesity. Forty-four participants were randomized to a Placebo group, which received sham transcutaneous electrical stimulation paired with positive suggestions, or to a Control group. Endurance (repetitions), perceived exertion (RPE load), and the late Readiness Potential were recorded during a finger-flexion task performed to exhaustion at 60% 1-RM in two sessions separated by 30 min of rest. Outcomes (Repetitions, RPE load, and RP amplitude) were expressed as percentage change (Δ%) from baseline to test, and group differences were analysed through one-way ANOVAs. Compared with Controls, the Placebo group exhibited smaller declines in repetitions and RPE load and a smaller increase in RP amplitude. Outcomes are in line with a reduced perceived fatigue. These findings suggest that positive expectations can alleviate perceived fatigue and reduce the cortical cost of motor preparation in obesity. Randomized Experimental Trial.
Keywords:
Placebo
Fatigue
Motor performance
Obesity
Readiness potential
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
E
IF:
0
Papers:
69
Citations:
0
View more organizations